F-18FDG uptake due to acinetobacter infection causing misinterpretation of treatment response in a lymphoma patient

Yildiz R., Coskun U., Kapucu O., Kaya A. O., Akdemir Ü. Ö., Benekli M., ...More

CLINICAL NUCLEAR MEDICINE, vol.32, no.6, pp.471-473, 2007 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Editorial Material
  • Volume: 32 Issue: 6
  • Publication Date: 2007
  • Doi Number: 10.1097/rlu.0b013e318053ed08
  • Journal Name: CLINICAL NUCLEAR MEDICINE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.471-473
  • Gazi University Affiliated: Yes

Abstract

A 59-year-old woman, diagnosed with diffuse large B-cell lymphoma 4 months ago by biopsy from a right cervical lymph node, was hospitalized due to febrile neutropenia 10 days after the 5th cycle of R-CHOP chemotherapy. In the setting of monitoring therapy, new pulmonary lesions with mild F-18 FDG uptake after the 4th cycle of chemotherapy were illustrated. Acinetobacter was isolated from the cultures taken from these lesions by fiberoptic broncoscopy. Disappearance of these hew lesions after the treatment with sensitive antibiotics confirmed that this is a case of 18-F FDG uptake due to acinetobacter infection in a lymphoma patient.